Rankings
▼
Calendar
TLPH Q3 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena
TLPH
Talphera, Inc.
$18M
Q3 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$2M
Operating Income
-$4M
Net Income
-$3M
EPS (Diluted)
$-0.13
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$234,000
Balance Sheet
Total Assets
$21M
Total Liabilities
$11M
Stockholders' Equity
$10M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$117,000
-100.0%
Gross Profit
-$2M
-$1M
-93.5%
Operating Income
-$4M
-$3M
-13.3%
Net Income
-$3M
-$1M
-147.1%
← FY 2024
All Quarters
Q4 2024 →